Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDActual EPS
Petros Pharmaceuticals, Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|
Petros Pharmaceuticals, Inc. Earnings Date And Information
Petros Pharmaceuticals, Inc. last posted its earnings results on Monday, March 31st, 2025. The company reported $-0.11554 earnings per share for the quarter, topping analysts' consensus estimates of $-8.25 by $8.13446. The company had revenue of 0 for the quarter and had revenue of 5.11 M for the year. Petros Pharmaceuticals, Inc. has generated $0 earnings per share over the last year ($-0.0229 diluted earnings per share) and currently has a price-to-earnings ratio of -0. Petros Pharmaceuticals, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, September 3rd, 2025 based on prior year's report dates.
Petros Pharmaceuticals, Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 05/15/2025 | Q1 2025 | N/A | -$9.37 | N/A | N/A | $0 |
| 03/31/2025 | Q4 2024 | -$8.25 | -$0.13 | 8.12 | $1.28 M | $725.40 K |
| 11/13/2024 | Q3 2024 | -$0.29 | -$0.53 | -0.24 | $1.34 M | $1.58 M |
| 08/14/2024 | Q2 2024 | -$0.77 | -$0.37 | 0.4 | $1.42 M | $1.42 M |
| 05/15/2024 | Q1 2024 | N/A | -$1.69 | N/A | $1.39 M | $1.39 M |
| 05/31/2024 | Q4 2023 | N/A | -$2.10 | N/A | $1.55 M | $-364,250 |
| 11/15/2023 | Q3 2023 | N/A | -$2.85 | N/A | N/A | $1.67 M |
| 08/14/2023 | Q2 2023 | N/A | -$1.20 | N/A | N/A | $1.99 M |
| 05/15/2023 | Q1 2023 | N/A | -$0.66 | N/A | N/A | $2.52 M |
| 03/31/2023 | Q4 2022 | N/A | -$2.03 | N/A | N/A | $798.10 K |
| 11/14/2022 | Q3 2022 | N/A | -$6.69 | N/A | N/A | $-1,457,732 |
| 08/12/2022 | Q2 2022 | N/A | -$0.88 | N/A | N/A | $4.19 M |
| 05/16/2022 | Q1 2022 | N/A | -$0.08 | N/A | N/A | $2.47 M |
| 03/31/2022 | Q4 2021 | N/A | -$5.77 | N/A | N/A | $-867,160 |
| 11/15/2021 | Q3 2021 | N/A | -$1.73 | N/A | N/A | $2.15 M |
| 08/16/2021 | Q2 2021 | N/A | -$2.16 | N/A | N/A | $2.46 M |
| 05/14/2021 | Q1 2021 | N/A | $3.09 | N/A | N/A | $4.08 M |
| 03/31/2021 | Q4 2020 | N/A | -$4.92 | N/A | N/A | $2.93 M |
| 09/30/2020 | Q3 2020 | N/A | -$9.61 | N/A | N/A | $3.46 M |
| 06/30/2020 | Q2 2020 | N/A | -$16.78 | N/A | N/A | $1.37 M |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Petros Pharmaceuticals, Inc. Earnings: FAQ's
Petros Pharmaceuticals, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, September 3rd, 2025 based offlast year's report dates.
In the previous quarter, Petros Pharmaceuticals, Inc. (:PTPI) reported $-0.11554 earnings per share (EPS) to beat the analysts' consensus estimate of $-8.25 by $8.13446.
The conference call for Petros Pharmaceuticals, Inc.'s latest earnings report can be listened to online.
The conference call transcript for Petros Pharmaceuticals, Inc.'s latest earnings report can be read online.
Petros Pharmaceuticals, Inc. (:PTPI) has a recorded annual revenue of $5.11 M.
Petros Pharmaceuticals, Inc. (:PTPI) has a recorded net income of $-14,318,790.Petros Pharmaceuticals, Inc. has generated $-0.0229 earnings per share over the last four quarters.
Petros Pharmaceuticals, Inc. (:PTPI) has a price-to-earnings ratio of -0 and price/earnings-to-growth ratio is 0.